2009
DOI: 10.4161/cc.8.11.8579
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear receptors: Genomic and non-genomic effects converge

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
57
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 100 publications
(60 citation statements)
references
References 61 publications
1
57
0
Order By: Relevance
“…Because ERRα-dependent transcriptional activity is required for viral replication, the host cell may sequester ERRα in the cytoplasm in an attempt to limit infection. Even though nuclear receptors are most notable for altering gene expression by directly binding to target DNA sequences, additional functions have been described (52,53). As such, it is also conceivable that cytoplasmic ERRα binds host and/or viral proteins to regulate aspects of infection.…”
Section: Discussionmentioning
confidence: 99%
“…Because ERRα-dependent transcriptional activity is required for viral replication, the host cell may sequester ERRα in the cytoplasm in an attempt to limit infection. Even though nuclear receptors are most notable for altering gene expression by directly binding to target DNA sequences, additional functions have been described (52,53). As such, it is also conceivable that cytoplasmic ERRα binds host and/or viral proteins to regulate aspects of infection.…”
Section: Discussionmentioning
confidence: 99%
“…ERs drive gene cascades comprising primary genes, whose transcription is directly controlled by the hormone through physical interaction of ERs with regulatory sites in the genome (genomic pathway of ER action) and/or with signal transduction effectors (nongenomic pathway), as well as downstream genes whose activity depends on the functions encoded by the primary responders. 5,6 The identification of primary estrogen target genes, and the downstream gene cascade that stems from them, is being actively pursued because it will provide essential information on the molecular and genomic pathways of the hormone-responsive BC phenotype. This is an important asset in clinical oncology because effective endocrine treatments of BC with ER␣ antagonists or aromatase inhibitors would be greatly improved by reliable predictors of tumor sensitivity to these drugs in the adjuvant or metastatic settings, as well as by the availability of markers of pharmacological resistance and new therapeutic targets to overcome it.…”
Section: Luminal-like Breast Tumor Cells Express Estrogen Receptor ␣ mentioning
confidence: 99%
“…17 Remarkably, at least part of these extranuclear signaling pathways converges and contributes to the control of gene transcription by VDR. 18,19 Moreover, 1,25(OH) 2 D 3 regulates genes that seem to lack VDR binding sites 15 and exerts posttranslational gene regulatory effects by controlling the expression of multiple proteases and protease inhibitors. 20 In addition, in certain systems, VDR has been found to interact with other transcription regulators, such as β-catenin and FoxO factors having ligand-dependent or -independent effects.…”
Section: Vitamin D Modulates the Expression Of Histone Demethylase Genesmentioning
confidence: 99%